Cite

HARVARD Citation

    Kelderman, S. et al. (2016). Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy. European journal of immunology. 46 (6), pp. 1351-1360. [Online]. 
  
Back to record